Behavidence is a mental health technology monitoring and measuring company. Its app detects, monitors, and identifies the psychiatric and neurological conditions of users based on their digital usage patterns, with the help of Artificial Intelligence (AI), and it matches users' emotional stress while using their phones to clinical data points of individuals diagnosed with depression, anxiety, and Attention-Deficit/Hyperactivity Disorder (ADHD)–using passive biomarkers. The app then suggests behavioral changes and allows for journal keeping to track progress.
Behavidence operates on a D2C and B2B2C basis. In the B2B2C model, the company partners with healthcare providers, insurance providers, and employers to provide these services for their patients, customers and employees, respectively. It has secured more than USD 1 million in contracts and has established partnerships with entities such as the Department of Veteran Affairs, Discovery Health Insurance, and Essen Health Care. The company’s app is available to users in the US, Europe, and Africa and leverages these markets to refine its biomarkers.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.